Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle
BioTalk Unzipped21 Okt 2024

Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle

EP-23. In the second half of this compelling conversation on BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their deep dive with Scott Ogle, CEO of TruLab. They explore the surprising parallels between the banking and pharma industries, the game-changing role of digital twinning in clinical trials, and the biotech funding landscape. Scott also shares his thoughts on leadership, mentorship, and the impact of the Inflation Reduction Act on pharma innovation. This episode offers listeners valuable insights into the future of drug development and the challenges of balancing professional and personal life in a fast-paced industry.


Chapters

1:09 - Comparison of the Banking Industry to the Pharma Industry

5:18 - Data Integrity, Same For Decentralized Trials?

8:33 - Biotech Funding Trends

11:18 - NEW NEWS! – Digital Twinning in Clinical Trials

16:15 - What Advice Would You Give to Your Younger Self?

20:57 - Mentorship and Its Impact, How it Shaped Scott

23:45 - Balancing Work and Personal Life

24:32 - The Inflation Reduction Act and Innovation


Takeaways

  • The regulatory environment in pharma can slow down innovation.

  • Digital twinning in clinical trials could revolutionize drug development.

  • Family influences play a significant role in shaping business perspectives.

  • The need for a strong company culture to maintain values during growth.

  • Biotech funding trends are influenced by macroeconomic factors like interest rates.

  • The importance of mentorship in professional development.



Sound Bites

  • “The similarities between the banking industry and the pharma industry is eerily similar.”

  • “Quality is really what we do.”

  • “Being quality is core to software.”

  • “It’s really clear people care more about their money than they do their healthcare.”

  • “Biotech and large pharma seem to balance each other out.”

  • “The career for you is at the intersection of what you are good at and what you like to do.”

  • “If you’re good at something and you like to do it, it fuels your energy to keep getting better.”

  • “Enjoy the impact in what you’re doing and accomplishing!”


New News Story:


How to reach us:

Scott Ogle

https://www.linkedin.com/in/scott-ogle/

TruLab - https://trulab.com/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /

Image Credits

Digital Twinning - Credit Getty Images

Simulation - Credit: andrush / Adobe Stock

Tomáš Helikar - https://www.linkedin.com/in/tomashelikar/

Nebraska Swan computer - https://newsroom.unl.edu/announce/cse/16380/90600

Brian Hamilton - https://inmatestoentrepreneurs.org/board/brian-hamilton/

Avsnitt(41)

Navigating Challenges in Drug Discovery with Dr. Alfred Botchway

Navigating Challenges in Drug Discovery with Dr. Alfred Botchway

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alfred Botchway, CEO of Attentive Science, to discuss his journey in biomedical science and the groundbreakin...

7 Apr 202551min

2024 Year In Review: BioTalk Unzipped

2024 Year In Review: BioTalk Unzipped

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe reflect on their journey over the past year, discussing key themes and insights gained from their guests. They explore th...

17 Mars 202541min

Women in Pharmaceutical Sciences and their Allies with Dr. Ines Santos and Dr. Julie Sable

Women in Pharmaceutical Sciences and their Allies with Dr. Ines Santos and Dr. Julie Sable

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Ines Santos and Dr. Julia Sable to discuss their experiences and contributions in the pharmaceutical sciences, pa...

3 Mars 20251h 11min

Are AI Doctors coming soon? A Discussion about AI in Medical Devices. - with Dr. Alex Friedman

Are AI Doctors coming soon? A Discussion about AI in Medical Devices. - with Dr. Alex Friedman

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe welcome Dr. Alex Friedman, a seasoned expert in regulatory affairs for medical devices and AI as Software as a Medical De...

3 Feb 20251h 10min

Collaborating for Innovation: Biopharma Success with Dr. Nathan Teuscher

Collaborating for Innovation: Biopharma Success with Dr. Nathan Teuscher

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe continue their conversation with Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. They di...

20 Jan 202531min

The Future of Pharmacometrics with Dr. Nathan Teuscher

The Future of Pharmacometrics with Dr. Nathan Teuscher

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics. The conversation explores Nathan...

6 Jan 202533min

Insights from AAPS PharmSci 360 Live with Dr. Mark Arnold

Insights from AAPS PharmSci 360 Live with Dr. Mark Arnold

In this episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Dr. Mark Arnold, a distinguished bioanalytical thought leader. They discuss the impact of recent FDA regul...

30 Dec 202429min

Digital Twins: The Future of Drug Discovery with Dr. Tomáš Helikar

Digital Twins: The Future of Drug Discovery with Dr. Tomáš Helikar

BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe engage with Dr. Tomas Helikar in an exciting discussion on the future of AI, digital twins, and personalized medicine. From mathematical models ...

16 Dec 202437min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
rss-jossan-nina
rss-borsens-finest
rss-svart-marknad
uppgang-och-fall
rss-dagen-med-di
rss-inga-dumma-fragor-om-pengar
lastbilspodden
fill-or-kill
borsmorgon
avanzapodden
bilar-med-sladd
tabberaset
bathina-en-podcast
rss-veckans-trade
kvalitetsaktiepodden
rss-kort-lang-analyspodden-fran-di
svd-tech-brief